Literature DB >> 619947

Central nervous system depressant actions of clonidine and UK-14,304: partial dissociation of EEG and behavioural effects.

H Ashton, M D Rawlins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 619947      PMCID： PMC1429239          DOI： 10.1111/j.1365-2125.1978.tb01614.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  9 in total

1.  Clinical pharmacology and pharmacokinetics of clonidine.

Authors:  C T Dollery; D S Davies; G H Draffan; H J Dargie; C R Dean; J L Reid; R A Clare; S Murray
Journal:  Clin Pharmacol Ther       Date:  1976-01       Impact factor: 6.875

2.  Contingent negative variation amplitudes. Marihuana and alcohol.

Authors:  B S Kopell; J R Tinklenberg; L E Hollister
Journal:  Arch Gen Psychiatry       Date:  1972-12

Review 3.  The mechanisms of action of some antihypertensive drugs.

Authors:  R Laverty
Journal:  Br Med Bull       Date:  1973-05       Impact factor: 4.291

4.  The effect of caffeine, nitrazepam and cigarette smoking on the contingent negative variation in man.

Authors:  H Ashton; J E Millman; R Telford; J W Thompson
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1974-07

5.  Cortical and subcortical slow potentials in the monkey's brain during a preparatory interval.

Authors:  C S Rebert
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1972-10

6.  Increases in CNS excitability during negative cortical slow potentials in man.

Authors:  D W McAdam
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1969-02

7.  The effects of methamphetamine and secobarbital on the contingent negative variation amplitude.

Authors:  B S Kopell; W K Wittner; D T Lunde; L J Wolcott; J R Tinklenberg
Journal:  Psychopharmacologia       Date:  1974-01-09

8.  Amphetamine effects in man: paradoxical drowsiness and lowered electrical brain acitivity (CNV).

Authors:  J J Tecce; J O Cole
Journal:  Science       Date:  1974-08-02       Impact factor: 47.728

9.  Chlorpromazine effects on brain activity (contingent negative variation) and reaction time in normal women.

Authors:  J J Tecce; J O Cole; J Savignano-Bowman
Journal:  Psychopharmacologia       Date:  1975-09-17
  9 in total
  9 in total

1.  Differences in psychic performance with guanfacine and clonidine in normotensive subjects.

Authors:  J Kugler; R Seus; R Krauskopf; H M Brecht; A Raschig
Journal:  Br J Clin Pharmacol       Date:  1980       Impact factor: 4.335

2.  An alternative method of assessing changes in salivary flow: comparison of the effects of clonidine and tiamenidine (HOE 440).

Authors:  D Findlay; J R Lawrence
Journal:  Eur J Clin Pharmacol       Date:  1978-12-01       Impact factor: 2.953

3.  Interaction of selective alpha-adrenoceptor agonists and antagonists with human and rabbit blood platelets.

Authors:  J A Grant; M C Scrutton
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

4.  Effect of 781094, a new selective alpha-adrenoceptor antagonist, on the aggregatory responses of human blood platelets and on binding of [3H]-dihydroergocryptine to these cells.

Authors:  R Kerry; M C Scrutton
Journal:  Br J Pharmacol       Date:  1983-06       Impact factor: 8.739

Review 5.  Pharmacological profiles of alpha 2 adrenergic receptor agonists identified using genetically altered mice and isobolographic analysis.

Authors:  Carolyn A Fairbanks; Laura S Stone; George L Wilcox
Journal:  Pharmacol Ther       Date:  2009-04-23       Impact factor: 12.310

Review 6.  Drug interactions with alcohol.

Authors:  M Linnoila; M J Mattila; B S Kitchell
Journal:  Drugs       Date:  1979-10       Impact factor: 9.546

7.  Preliminary clinical pharmacological studies of S3341, a new hypotensive agent, and comparison with clonidine in normal males.

Authors:  K Weerasuriya; E Shaw; P Turner
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

8.  Contingent negative variation as a dopaminergic biomarker: evidence from dose-related effects of methylphenidate.

Authors:  Anke M W Linssen; Eric F P M Vuurman; Anke Sambeth; Stephane Nave; Will Spooren; Gabriel Vargas; Luca Santarelli; Wim J Riedel
Journal:  Psychopharmacology (Berl)       Date:  2011-05-20       Impact factor: 4.530

9.  The signaling and selectivity of α-adrenoceptor agonists for the human α2A, α2B and α2C-adrenoceptors and comparison with human α1 and β-adrenoceptors.

Authors:  Richard G W Proudman; Juliana Akinaga; Jillian G Baker
Journal:  Pharmacol Res Perspect       Date:  2022-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.